Kelley E. Capocelli
Alnylam Pharmaceuticals (United States)
ORCID: 0000-0002-8256-2896Also affiliated with Scholar Rock (United States)
Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
Indexed papers
Papers
Driven by 7 papers. Top paper: “One-food versus six-food elimination diet therapy for the treatment of eosinophilic oesophagitis: a multicentre, randomised, open-label trial”.
Nirmala Gonsalves, Evan S. Dellon, David A. Katzka, J. Pablo Abonia, Seema S. Aceves +25 more
Margaret H. Collins, Mark Rochman, Ting Wen, Julie M. Caldwell, Lydia E. Mack +80 more
A Deep Multi-Label Segmentation Network For Eosinophilic Esophagitis Whole Slide Biopsy Diagnostics
Ariel Larey, Eliel Aknin, G. A. Osswald, Julie M. Caldwell, Mark Rochman +7 more
Ting Wen, Julie M. Caldwell, Netali Ben-Baruch Morgenstern, G. A. Osswald, Mark Rochman +81 more
Lili Sun, Margaret H. Collins, Peter A Bonis, Nicoleta C. Arva, Kelley E. Capocelli +19 more
Amanda K. Rudman Spergel, Ikuo Hirano, Tetsuo Shoda, Xue Zhang, Lisa J. Martin +24 more
Gary E. Markey, Juliet A Hammer, Luke Simerly, Monika Dzieciątkowska, Kimberly R. Jordan +13 more